申请人:——
公开号:US20030171390A1
公开(公告)日:2003-09-11
Compounds of formula 1 modulate the activity of Rho C:
1
wherein R
1
is H, OH, or lower alkyl;
R
2
, R
3
, R
4
, R
5
, and R
6
are each independently H, halo, lower alkyl, OH, lower alkoxy, NH
2
, lower alkylamino, di(lower alkyl)amino, SH, lower alkylthio, NO
2
, or two residues together form a heterocyclic ring;
R
7
, R
8
, R
9
, and R
10
are each independently H, lower alkyl, OH, NH
2
, aryl, or aralkyl, where aryl and aralkyl are substituted with 0-3 moieties selected from the group consisting of halo, OH, NH
2
, lower alkyl, lower alkoxy, SH, lower alkylthio, and lower alkylamino;
R
11
, R
12
, R
13
, R
14
, R
15
, and R
16
are each independently H, halo, lower alkyl, OH, lower alkoxy, or NO
2
;
or a pharmaceutically acceptable salt thereof
式 1 的化合物可调节 Rho C 的活性:
1
其中 R
1
是 H、OH 或低级烷基;
R
2
, R
3
, R
4
, R
5
和 R
6
各自独立地为 H、卤代、低级烷基、OH、低级烷氧基、NH
2
、低级烷基氨基、二(低级烷基)氨基、SH、低级烷硫基、NO
2
或两个残基共同形成一个杂环;
R
7
, R
8
, R
9
和 R
10
各自独立地为 H、低级烷基、OH、NH
2
芳基或芳烷基,其中芳基和芳烷基被 0-3 个分子取代,这些分子选自卤代、OH、 NH
2
、低级烷基、低级烷氧基、SH、低级烷硫基和低级烷氨基;
R
11
, R
12
, R
13
, R
14
, R
15
和 R
16
各自独立地为 H、卤代、低级烷基、OH、低级烷氧基或 NO
2
;
或其药学上可接受的盐